Abstract
Cell-free DNA (cfDNA) is commonly found in the blood (plasma) of patients with cancer. When analysing cfDNA for a specific cancer-causing mutation, it is referred to as ctDNA.RB1ctDNA is commonly present in the blood of retinoblastoma patients. We examinedRB1ctDNA from blood of 40 children with retinoblastoma look alike lesions (‘pseudoretinoblastoma’) to determine if anyRB1abnormalities could be identified.ObjectivesBecause retinoblastoma diagnosis is usually made with the indirect ophthalmoscope without biopsy clinical errors continue to occur worldwide. Because cfRB1is detectible in plasma of children with retinoblastoma, we wondered if it was present in the blood of pseudoretinoblastomas with the hope of ultimately developing a blood based test to aid clinicians in the diagnosis of retinoblastoma. The goal of this project was to see if circulating plasmaRB1cfDNA could be detected in the blood of patients with pseudoretinoblastoma.Methods and analysisPlasma cfDNA for circulatingRB1cfDNA was assayed with MSKCC’s next generation sequencing, N.Y. State Approved assay called ACCESS to evaluate somaticmutations in 40 patients with pseudoretinoblastoma.ResultsNo plasma cfDNARB1was detected in the blood (plasma) of 40 patients with pseudoretinoblastoma.ConclusionPlasma cfDNARB1is commonly detectible in retinoblastoma patients but not in patients with a diverse group of pseudoretinoblastomas.
Funder
Fund for Ophthalmic Knowledge
Gerber Foundation
Cancer Center Support Grant